Clinical Trials

Epizyme is exploring the potential of tazemetostat, its lead investigational agent, as a treatment for patients with difficult to treat forms of cancer in multiple clinical trials.

Clinical trials are a critical part of the drug development process designed to assess an investigational agent’s safety and effectiveness in treating a disease, adding to the industry knowledge on diseases and how they may be treated.

For information regarding access to Epizyme’s clinical trials, please visit epizymeclinicaltrials.com. You can also email us at clinicaltrials@epizyme.com or call us at 855-500-1011 (U.S. toll-free).

EPZM Clinical Trials